脑部放疗，上午比下午敏感许多！ u# I, B( ~$ g8 [; i4 A9 I
! ?: I: \! H- Y* `1 W2 Q$ B3 I# Z
* k6 w8 j$ z& F( U' f) \9 l
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.9 R) o, W2 v* R
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?! \* r8 K& v z5 i0 V) e( G8 ~
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.3 w7 L4 i/ _5 A" E. u
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
3 r K |) f! j7 V% {/ m. `, H3 [' K& p0 y; l) [5 d
Abstract( d1 q5 o6 w# \' L: j9 j# W! f
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.6 V3 ?; p$ `/ ]$ Z% v
" P- Y5 `1 h+ D$ b+ JMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
, R& E0 u5 l9 t6 M' | P/ a
1 F. P, d( [ y5 \RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
8 m7 u" X' ^' ^$ g& h
5 u ?/ U8 m5 ?! f/ X( y) ]! P% BCONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.3 g3 R. A% P+ r. k# B* v, K
6 ?! u" m& c, g& y+ N
|
4 O& \* @ Z9 @- y
显身卡
